Ameritas Investment Company’s Prothena Corp PRTA Stock Holding History

Ameritas Investment Company’s Portfolio PRTA Stock Details PRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-2	Closed	–	–	1579
2018 Q4	$0	Buy	+2	New	+$24	﹤0.01%	1562

Other funds holding PRTA

WIM

Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameritas Investment Company's PRTA Position: Q1 2019 in Review

Ameritas Investment Company sold out of Prothena Corp (PRTA) in Q1 2019, closing a stake of 2 shares.

Ameritas Investment Company first reported a position in PRTA in Q4 2018 and held it in 1 quarter. The position peaked at $0 in Q4 2018. 139 funds tracked by Wall St. Rank hold PRTA as of Q1 2019.

Ameritas Investment Company reported no remaining Prothena Corp position as of Q1 2019 after selling out during the quarter.
Ameritas Investment Company sold 2 Prothena Corp shares in Q1 2019.
Ameritas Investment Company first reported a position in Prothena Corp in Q4 2018 and held it in 1 quarter.
Ameritas Investment Company's Prothena Corp position peaked at $0 in Q4 2018.
139 funds tracked by Wall St. Rank held Prothena Corp as of Q1 2019.

Based on Ameritas Investment Company's 13F filing for Q1 2019, filed 16 May 2019.